Newsfeeds Archive - Page 3 of 4

2 minute read

NVIDIA To Rally Around 22%? Here Are 10 Other Analyst Forecasts For Monday

May 22, 8:02 AM

Needham cut the price target for Wix.com Ltd. (NASDAQ: WIX) from $125 to $120. Needham analyst Bernie McTernan maintained a Buy rating. Wix.com shares dropped 3.2% to close at $78.09 on Friday.

DKNG

1 minute read

FDA
News

Krystal Biotech Receives FDA Approval For First-Ever Redosable Gene Therapy, VYJUVEK For Treatment Of Dystrophic Epidermolysis Bullosa

By Benzinga Newsdesk

May 19, 2:04 PM

Dystrophic Epidermolysis Bullosa (DEB) is a serious rare genetic disease that affects the skin and mucosal tissues and is caused by one or more mutations in the COL7A1 gene, resulting in lack of production of

KRYS

16 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For April 18, 2023

By Benzinga Insights

April 18, 11:00 AM

Upgrades Canaccord Genuity upgraded the previous rating for Sigma Lithium Corp (NASDAQ:SGML) from Speculative Buy to Buy. The…

AQN

1 minute read

News

Jeune Aesthetics Treats First Subject in Phase 1, Cohort 3 Study of KB301 for the Improvement of Lateral Canthal Lines at Rest

By Benzinga Newsdesk

April 18, 7:02 AM

Jeune Aesthetics, Inc. ("Jeune"), a wholly-owned subsidiary of Krystal Biotech, Inc. ("Krystal") (NASDAQ:KRYS), today announced treatment of the first subject in the Phase 1,

KRYS

1 minute read

Goldman Sachs Upgrades Krystal Biotech to Buy, Raises Price Target to $124

By Benzinga Newsdesk

February 28, 5:53 AM

Goldman Sachs analyst Madhu Kumar upgrades Krystal Biotech (NASDAQ:KRYS) from Neutral to Buy and raises the price target from $79 to $124.

KRYS

1 minute read

Chardan Capital Reiterates Buy on Krystal Biotech, Maintains $133 Price Target

By Benzinga Newsdesk

February 28, 5:39 AM

Chardan Capital analyst Geulah Livshits reiterates Krystal Biotech (NASDAQ:KRYS) with a Buy and maintains $133 price target.

KRYS

2 minute read

Have A Look At William Blair’s Top Biotech Picks For 2023

By Vandana Singh

December 25, 2:32 PM

William Blair & Company's report outlined some key themes and significant trends to monitor while entering 2023, providing its top stock ideas for the upcoming 12-month period.

ALBO

2 minute read

New England Journal Of Medicine Publishes Phase 3 Data On B-VEC In Patients With Dystrophic Epidermolysis Bullosa

By Michael Horton

December 14, 6:03 PM

Krystal Biotech, Inc. (the "Company") (NASDAQ:KRYS), a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases, announced today that data from the

KRYS

1 minute read

Earnings

Recap: Krystal Biotech Q3 Earnings

By Benzinga Insights

November 7, 8:26 AM

Krystal Biotech (NASDAQ:KRYS) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

KRYS

14 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 25, 2022

By Benzinga Insights

August 25, 10:34 AM

Upgrades